Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.

PTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial cells) at the inflammatory site. It appears to have a cardiovascular protective function by acting on the immune-inflammatory balance in the car...

Full description

Bibliographic Details
Main Authors: Elisa Barbati, Claudia Specchia, Massimo Villella, Marco Luciano Rossi, Simona Barlera, Barbara Bottazzi, Luisa Crociati, Carmela d'Arienzo, Raffaele Fanelli, Cecilia Garlanda, Francesca Gori, Ruggiero Mango, Alberto Mantovani, Giuseppe Merla, Enrico B Nicolis, Silvia Pietri, Patrizia Presbitero, Yukio Sudo, Alessandro Villella, Maria Grazia Franzosi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3532160?pdf=render
_version_ 1819058965791637504
author Elisa Barbati
Claudia Specchia
Massimo Villella
Marco Luciano Rossi
Simona Barlera
Barbara Bottazzi
Luisa Crociati
Carmela d'Arienzo
Raffaele Fanelli
Cecilia Garlanda
Francesca Gori
Ruggiero Mango
Alberto Mantovani
Giuseppe Merla
Enrico B Nicolis
Silvia Pietri
Patrizia Presbitero
Yukio Sudo
Alessandro Villella
Maria Grazia Franzosi
author_facet Elisa Barbati
Claudia Specchia
Massimo Villella
Marco Luciano Rossi
Simona Barlera
Barbara Bottazzi
Luisa Crociati
Carmela d'Arienzo
Raffaele Fanelli
Cecilia Garlanda
Francesca Gori
Ruggiero Mango
Alberto Mantovani
Giuseppe Merla
Enrico B Nicolis
Silvia Pietri
Patrizia Presbitero
Yukio Sudo
Alessandro Villella
Maria Grazia Franzosi
author_sort Elisa Barbati
collection DOAJ
description PTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial cells) at the inflammatory site. It appears to have a cardiovascular protective function by acting on the immune-inflammatory balance in the cardiovascular system. PTX3 plasma concentration is an independent predictor of mortality in patients with acute myocardial infarction (AMI) but the influence of PTX3 genetic variants on PTX3 plasma concentration has been investigated very little and there is no information on the association between PTX3 variations and AMI. Subjects of European origin (3245, 1751 AMI survivors and 1494 controls) were genotyped for three common PTX3 polymorphisms (SNPs) (rs2305619, rs3816527, rs1840680). Genotype and allele frequencies of the three SNPs and the haplotype frequencies were compared for the two groups. None of the genotypes, alleles or haplotypes were significantly associated with the risk of AMI. However, analysis adjusted for age and sex indicated that the three PTX3 SNPs and the corresponding haplotypes were significantly associated with different PTX3 plasma levels. There was also a significant association between PTX3 plasma concentrations and the risk of all-cause mortality at three years in AMI patients (OR 1.10, 95% CI: 1.01-1.20, p = 0.02). Our study showed that PTX3 plasma levels are influenced by three PTX3 polymorphisms. Genetically determined high PTX3 levels do not influence the risk of AMI, suggesting that the PTX3 concentration itself is unlikely to be even a modest causal factor for AMI. Analysis also confirmed that PTX3 is a prognostic marker after AMI.
first_indexed 2024-12-21T14:03:35Z
format Article
id doaj.art-d90cee926a394e0fa636452847d7ef13
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T14:03:35Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d90cee926a394e0fa636452847d7ef132022-12-21T19:01:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5303010.1371/journal.pone.0053030Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.Elisa BarbatiClaudia SpecchiaMassimo VillellaMarco Luciano RossiSimona BarleraBarbara BottazziLuisa CrociatiCarmela d'ArienzoRaffaele FanelliCecilia GarlandaFrancesca GoriRuggiero MangoAlberto MantovaniGiuseppe MerlaEnrico B NicolisSilvia PietriPatrizia PresbiteroYukio SudoAlessandro VillellaMaria Grazia FranzosiPTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial cells) at the inflammatory site. It appears to have a cardiovascular protective function by acting on the immune-inflammatory balance in the cardiovascular system. PTX3 plasma concentration is an independent predictor of mortality in patients with acute myocardial infarction (AMI) but the influence of PTX3 genetic variants on PTX3 plasma concentration has been investigated very little and there is no information on the association between PTX3 variations and AMI. Subjects of European origin (3245, 1751 AMI survivors and 1494 controls) were genotyped for three common PTX3 polymorphisms (SNPs) (rs2305619, rs3816527, rs1840680). Genotype and allele frequencies of the three SNPs and the haplotype frequencies were compared for the two groups. None of the genotypes, alleles or haplotypes were significantly associated with the risk of AMI. However, analysis adjusted for age and sex indicated that the three PTX3 SNPs and the corresponding haplotypes were significantly associated with different PTX3 plasma levels. There was also a significant association between PTX3 plasma concentrations and the risk of all-cause mortality at three years in AMI patients (OR 1.10, 95% CI: 1.01-1.20, p = 0.02). Our study showed that PTX3 plasma levels are influenced by three PTX3 polymorphisms. Genetically determined high PTX3 levels do not influence the risk of AMI, suggesting that the PTX3 concentration itself is unlikely to be even a modest causal factor for AMI. Analysis also confirmed that PTX3 is a prognostic marker after AMI.http://europepmc.org/articles/PMC3532160?pdf=render
spellingShingle Elisa Barbati
Claudia Specchia
Massimo Villella
Marco Luciano Rossi
Simona Barlera
Barbara Bottazzi
Luisa Crociati
Carmela d'Arienzo
Raffaele Fanelli
Cecilia Garlanda
Francesca Gori
Ruggiero Mango
Alberto Mantovani
Giuseppe Merla
Enrico B Nicolis
Silvia Pietri
Patrizia Presbitero
Yukio Sudo
Alessandro Villella
Maria Grazia Franzosi
Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
PLoS ONE
title Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
title_full Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
title_fullStr Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
title_full_unstemmed Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
title_short Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.
title_sort influence of pentraxin 3 ptx3 genetic variants on myocardial infarction risk and ptx3 plasma levels
url http://europepmc.org/articles/PMC3532160?pdf=render
work_keys_str_mv AT elisabarbati influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT claudiaspecchia influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT massimovillella influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT marcolucianorossi influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT simonabarlera influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT barbarabottazzi influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT luisacrociati influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT carmeladarienzo influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT raffaelefanelli influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT ceciliagarlanda influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT francescagori influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT ruggieromango influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT albertomantovani influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT giuseppemerla influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT enricobnicolis influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT silviapietri influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT patriziapresbitero influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT yukiosudo influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT alessandrovillella influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels
AT mariagraziafranzosi influenceofpentraxin3ptx3geneticvariantsonmyocardialinfarctionriskandptx3plasmalevels